85 related articles for article (PubMed ID: 24269782)
1. Interaction between 14-3-3β and PrP influences the dimerization of 14-3-3 and fibrillization of PrP106-126.
Han J; Song QQ; Sun P; Zhang J; Wang X; Song J; Li GQ; Liu YH; Mei GY; Shi Q; Tian C; Chen C; Gao C; Zhao B; Dong XP
Int J Biochem Cell Biol; 2014 Feb; 47():20-8. PubMed ID: 24269782
[TBL] [Abstract][Full Text] [Related]
2. [Study on PrP106-126 peptide disturbed dimeration of 14-3-3beta].
Song QQ; Sun P; Song J; Sheng LJ; Zhang J; Han J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Apr; 27(2):109-11. PubMed ID: 24044214
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 104 inhibited the fibrillization of prion peptide 106-126 and disassembled prion peptide 106-126 fibrils in vitro.
Liu YH; Han YL; Song J; Wang Y; Jing YY; Shi Q; Tian C; Wang ZY; Li CP; Han J; Dong XP
Int J Biochem Cell Biol; 2011 May; 43(5):768-74. PubMed ID: 21296677
[TBL] [Abstract][Full Text] [Related]
4. [Interaction between various 14-3-3beta segments and PrP in vitro].
Liu YH; Han YL; Song J; Wang Y; Zhou W; Zhang BY; Tian C; Li CP; Han J; Dong XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Jun; 24(3):165-7. PubMed ID: 21186515
[TBL] [Abstract][Full Text] [Related]
5. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
[TBL] [Abstract][Full Text] [Related]
6. Molecular interaction of TPPP with PrP antagonized the CytoPrP-induced disruption of microtubule structures and cytotoxicity.
Zhou RM; Jing YY; Guo Y; Gao C; Zhang BY; Chen C; Shi Q; Tian C; Wang ZY; Gong HS; Han J; Xu BL; Dong XP
PLoS One; 2011; 6(8):e23079. PubMed ID: 21857997
[TBL] [Abstract][Full Text] [Related]
7. An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells.
Kazlauskaite J; Young A; Gardner CE; Macpherson JV; Vénien-Bryan C; Pinheiro TJ
Biochem Biophys Res Commun; 2005 Mar; 328(1):292-305. PubMed ID: 15670783
[TBL] [Abstract][Full Text] [Related]
8. Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation.
Corsaro A; Thellung S; Villa V; Principe DR; Paludi D; Arena S; Millo E; Schettini D; Damonte G; Aceto A; Schettini G; Florio T
Ann N Y Acad Sci; 2003 Dec; 1010():610-22. PubMed ID: 15033801
[TBL] [Abstract][Full Text] [Related]
9. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D
Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
[TBL] [Abstract][Full Text] [Related]
10. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
Prusiner SB
Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
[TBL] [Abstract][Full Text] [Related]
12. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
Walsh P; Simonetti K; Sharpe S
Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous deamidation and isomerization of Asn108 in prion peptide 106-126 and in full-length prion protein.
Sandmeier E; Hunziker P; Kunz B; Sack R; Christen P
Biochem Biophys Res Commun; 1999 Aug; 261(3):578-83. PubMed ID: 10441469
[TBL] [Abstract][Full Text] [Related]
14. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.
Tagliavini F; Forloni G; Colombo L; Rossi G; Girola L; Canciani B; Angeretti N; Giampaolo L; Peressini E; Awan T; De Gioia L; Ragg E; Bugiani O; Salmona M
J Mol Biol; 2000 Jul; 300(5):1309-22. PubMed ID: 10903871
[TBL] [Abstract][Full Text] [Related]
15. Molecular properties of complexes formed between the prion protein and synthetic peptides.
Kaneko K; Wille H; Mehlhorn I; Zhang H; Ball H; Cohen FE; Baldwin MA; Prusiner SB
J Mol Biol; 1997 Jul; 270(4):574-86. PubMed ID: 9245588
[TBL] [Abstract][Full Text] [Related]
16. Influence of gold-bipyridyl derivants on aggregation and disaggregation of the prion neuropeptide PrP106-126.
Zhao C; Wang X; He L; Zhu D; Wang B; Du W
Metallomics; 2014 Nov; 6(11):2117-25. PubMed ID: 25273168
[TBL] [Abstract][Full Text] [Related]
17. Palladium complexes affect the aggregation of human prion protein PrP106-126.
Wang Y; Feng L; Zhang B; Wang X; Huang C; Li Y; Du W
Inorg Chem; 2011 May; 50(10):4340-8. PubMed ID: 21504185
[TBL] [Abstract][Full Text] [Related]
18. Post-translational hydroxylation at the N-terminus of the prion protein reveals presence of PPII structure in vivo.
Gill AC; Ritchie MA; Hunt LG; Steane SE; Davies KG; Bocking SP; Rhie AG; Bennett AD; Hope J
EMBO J; 2000 Oct; 19(20):5324-31. PubMed ID: 11032800
[TBL] [Abstract][Full Text] [Related]
19. PrPSc-like prion protein peptide inhibits the function of cellular prion protein.
Brown DR
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):511-8. PubMed ID: 11085945
[TBL] [Abstract][Full Text] [Related]
20. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
